GRAFT-VERSUS-HOST DISEASE (GVHD)
Clinical trials for GRAFT-VERSUS-HOST DISEASE (GVHD) explained in plain language.
Never miss a new study
Get alerted when new GRAFT-VERSUS-HOST DISEASE (GVHD) trials appear
Sign up with your email to follow new studies for GRAFT-VERSUS-HOST DISEASE (GVHD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Fish oil infusions tested to tame transplant complications
Disease control ENROLLING_BY_INVITATIONThis study tests whether daily infusions of omega-3 fatty acids can lower the risk and severity of acute graft-versus-host disease (aGVHD) in 30 adults receiving a stem cell transplant. Participants get omega-3 alongside standard nutrition from the start of their conditioning the…
Matched conditions: GRAFT-VERSUS-HOST DISEASE (GVHD)
Phase: PHASE1, PHASE2 • Sponsor: Fujian Medical University • Aim: Disease control
Last updated May 26, 2026 09:01 UTC
-
New combo therapy aims to shield gut in transplant patients
Disease control TerminatedThis study was designed to test whether adding a drug called 5-azacytidine (AZA) to standard steroid treatment is safe and feasible for people with gut graft-versus-host disease (GVHD) after a stem cell transplant. GVHD occurs when donor cells attack the patient's body, and gut i…
Matched conditions: GRAFT-VERSUS-HOST DISEASE (GVHD)
Phase: EARLY_PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 08:57 UTC